Table of Contents
Organic Chemistry International
Volume 2013, Article ID 631723, 8 pages
Research Article

Synthesis of Pyrazine Substituted 1,3,4-Thiadiazole Derivatives and Their Anticonvulsant Activity

1Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India
2PG Department of Chemistry, JSS College of Arts, Commerce and Science, Ooty Road, Mysore 570025, India

Received 1 April 2013; Revised 13 September 2013; Accepted 13 September 2013

Academic Editor: Ashraf Aly Shehata

Copyright © 2013 Kikkeri P. Harish et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy,” Epilepsia, vol. 34, no. 4, pp. 592–596, 1993.
  2. R. S. Fisher, W. van Emde Boas, W. Blume et al., “Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE),” Epilepsia, vol. 46, no. 4, pp. 470–472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, Aetiogy, Epidemiology and Prognosis, World Health Organization, Lyon, France, 2001.
  4. R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, and E. A. Swinyard, “Antiepileptic drug development—II: anticonvulsant drug screening,” Epilepsia, vol. 19, no. 4, pp. 409–428, 1978. View at Google Scholar · View at Scopus
  5. E. I. Isaacson, “Central nervous system depressants,” in Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, J. N. Delgado and W. A. Remers, Eds., pp. 435–461, Lippincott-Raven, Philadelphia, Pa, USA, 1998. View at Google Scholar
  6. T. L. Lemke, D. A. Williams, V. F. Roche, and S. W. Zito, Foye's Principles of Medicinal Chemistry, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 6th edition, 2007.
  7. W. Van Bebenburg, G. Steinmetz, and K. Thielek, “Substituierte polyaminopyridine,” Chemiker-Zeitung, vol. 103, pp. 387–399, 1979. View at Google Scholar
  8. R. P. Shank, J. F. Gardocki, A. J. Streeter, and B. E. Maryanoff, “An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action,” Epilepsia, vol. 41, supplement 1, pp. S3–S9, 2000. View at Google Scholar · View at Scopus
  9. M. Kubota, M. Nishi-Nagase, Y. Sakakihara et al., “Zonisamide—induced urinary lithiasis in patients with intractable epilepsy,” Brain and Development, vol. 22, no. 4, pp. 230–233, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Cramer, R. Fisher, E. Ben-Menachem, J. French, and R. H. Mattson, “New antiepileptic drugs: comparison of key clinical trials,” Epilepsia, vol. 40, no. 5, pp. 590–600, 1999. View at Google Scholar · View at Scopus
  11. S. W. Schneller and J. K. Luo, “Composition antiviral activity of substituted azaindoleoxoacetic piperazine derivative,” Journal of Organic Chemistry, vol. 45, no. 20, pp. 4045–4048, 1980. View at Publisher · View at Google Scholar
  12. O. Vitse, P. Bonnet, J. Bompart et al., “Nitration in the imidazo[1,2-a]pyrazine series. Experimental and computational results,” Journal of Heterocyclic Chemistry, vol. 34, no. 3, pp. 701–707, 1997. View at Google Scholar · View at Scopus
  13. P. A. Bonnet, A. Michel, F. Laurent et al., “Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazines,” Journal of Medicinal Chemistry, vol. 35, no. 18, pp. 3353–3358, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Azam, I. A. Ibn-Rajab, and A. A. Alruiad, “Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships,” Pharmazie, vol. 64, no. 12, pp. 771–795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Lalezari, A. Shafiee, A. Badaly et al., “Synthesis and pharmacological activity of 5 substituted 2 (N,N dialkylaminoethyl)amino and 2-N-methylpiperazinyl 1,3,4 thiadiazoles,” Journal of Pharmaceutical Sciences, vol. 64, no. 7, pp. 1250–1252, 1975. View at Google Scholar · View at Scopus
  16. P. Bhattacharya, J. T. Leonard, and K. Roy, “Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques,” Bioorganic and Medicinal Chemistry, vol. 13, no. 4, pp. 1159–1165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Shiradkar, M. Ghodake, K. G. Bothara et al., “Synthesis and anticonvulsant activity of clubbed thiazolidinone-barbituric acid and thiazolidinone-triazole derivatives,” Arkivoc, vol. 2007, no. 14, pp. 58–74, 2007. View at Google Scholar · View at Scopus
  18. A. A. Ahmadu, A. U. Zezi, and A. H. Yaro, “Anti-diarrheal activity of the leaf extracts of Daniellia oliveri hutch and Dalz (Fabaceae) and ficus sycomorus Miq (Moraceae),” African Journal of Traditional, Complementary and Alternative Medicines, vol. 4, no. 4, pp. 524–528, 2007. View at Google Scholar · View at Scopus
  19. M. V. Diurno, O. Mazzoni, G. Correale et al., “Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonists,” Il Farmaco, vol. 54, no. 9, pp. 579–583, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. D. Firke, B. M. Firake, R. Y. Chaudhari, and V. R. Patil, “Synthetic and pharmacological evaluation of some pyridine containing thiazolidinones,” Asian Journal of Research in Chemistry, vol. 2, pp. 157–161, 2009. View at Google Scholar
  21. T. Kato, T. Ozaki, and N. Ohi, “Improved synthetic methods of CP-060S, a novel cardioprotective drug,” Tetrahedron Asymmetry, vol. 10, no. 20, pp. 3963–3968, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Havrylyuk, B. Zimenkovsky, and R. Lesyk, “Synthesis and anticancer activity of novel nonfused bicyclic thiazolidinone derivatives,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 184, no. 3, pp. 638–650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. S. Andotra and B. S. Manhas, “Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4-oxadiazoles,” Acta Ciencia Indica, Series Chemistry, vol. 18, pp. 99–108, 1992. View at Google Scholar
  24. A. M. M. E. Omar and O. M. AboulWafa, “Synthesis and anticonvulsant properties of a novel series of 2-substituted amino-5-aryl-1,3,4-oxadiazole derivatives,” Journal of Heterocyclic Chemistry, vol. 21, no. 5, pp. 1415–1418, 1984. View at Google Scholar · View at Scopus
  25. H. G. Vogel and W. H. Vogel, Drug Discovery and Evaluation: Pharmacological Assays, vol. 2, Springer, Berlin, Germany, 1997.